Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Lao People's Democratic Republic
Lao People's Democratic Republic: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.6% in 2024. ▼ Falling
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Lao People's Democratic Republic, 2015–2024
Source: United Nations Statistics Division, SDG Global Database. Measured in %.
Analysis
Lao People's Democratic Republic recorded 0.6% for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in 2024. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 66.7% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Lao People's Democratic Republic peaked at 1.8% in 2015 and was at its lowest, 0.6%, in 2023.
Lao People's Democratic Republic ranks 60th of 246 countries on this measure, in the top quarter.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Lao People's Democratic Republic, year by year
| Year | % | Change |
|---|---|---|
| 2015 | 1.8% | — |
| 2016 | 1.5% | -16.7% |
| 2017 | 1.3% | -13.3% |
| 2018 | 1.1% | -15.4% |
| 2019 | 0.8% | -27.3% |
| 2020 | 0.8% | +0.0% |
| 2021 | 0.7% | -12.5% |
| 2022 | 0.7% | +0.0% |
| 2023 | 0.6% | -14.3% |
| 2024 | 0.6% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.3% | 0.8% | 1.8% | 5 |
| 2020s | 0.7% | 0.6% | 0.8% | 5 |
Countries ranked near Lao People's Democratic Republic
- 60 Côte d'Ivoire 0.6% compare
- 60 Ethiopia 0.6% compare
- 60 Madagascar 0.6% compare
- 60 Micronesia (Federated States of) 0.6% compare
- 60 Naoero 0.6% compare
- 60 Northern Mariana Islands 0.6% compare
- 60 Palau 0.6% compare
- 60 Tonga 0.6% compare
- 60 Côte d'Ivoire 0.6% compare
- 60 Lao People's Democratic Republic 0.6% compare
More development goals data for Lao People's Democratic Republic
- Red List Index 0.8764 index (2025)
- Number of refugees per 100,000 population, by country of origin 82.71 per 100,000 people (2025)
- Manufacturing value added per capita 252.05 constant US$ (2025)
- Number of transboundary breeds 9 (2025)
- Number of transboundary breeds (not extinct) 9 (2025)
- Number of transboundary breeds with unknown risk status 9 (2025)
- Number of local breeds with unknown risk status 16 (2025)
- Number of local breeds (not extinct) 16 (2025)
- Number of local breeds kept in the country 16 (2025)
- Infant deaths 4,402 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Lao People's Democratic Republic?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Lao People's Democratic Republic was 0.6% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Lao People's Democratic Republic?
- The highest recorded value was 1.8% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Lao People's Democratic Republic?
- The lowest recorded value was 0.6% in 2023.
- How does Lao People's Democratic Republic rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Lao People's Democratic Republic ranks 60th out of 246 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Lao People's Democratic Republic?
- Over the last ten years it is down 66.7%. The long-run trend across the full record is falling.
- Where does this Lao People's Democratic Republic data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).